JERUSALEM, Israel — Teva Pharmaceutical Industries Ltd. has released ezetimibe tablets 10 mg, a cholesterol-lowering medication, in the United States.
Teva said its ezetimibe product is a generic version of Zetia tablets from Merck & Co.
Ezetimibe tablets work to reduce the amount of cholesterol the body absorbs. The drug is used to lower levels of total cholesterol and low-density lipoprotein (LDL) cholesterol in the blood and is indicated for patients who can’t control their cholesterol levels by diet and exercise alone.
The medication can be used by itself or with other medicines to treat high cholesterol, according to Teva.
“Despite advances in the treatment of high cholesterol in recent years, many people are still living with active disease and are in need of additional generic therapeutic options,” stated Dipankar Bhattacharjee, president and and chief executive officer of the Teva Global Generic Medicines unit. “We are excited to add another strong generic to our U.S. portfolio and see potential to build on its success by leveraging our expertise in the cardiovascular area.”
The American Heart Association (AHA) estimated that about a third of U.S. adults — 73.5 million people — have high LDL cholesterol, Teva reported. Fewer than 50% are being treated for high LDL cholesterol, and about 30% have their condition under control.
U.S. sales of ezetimibe tablets totaled approximately $2.7 billion for the 12 months through the end of March, according to IMS Health data cited by Teva.